Michal Stark

Arabinogalactan−Folic Acid−Drug Conjugate for Targeted Delivery and Target-Activated Release of Anticancer Drugs to Folate Receptor-Overexpressing Cells

Roy I. Pinhassi, Yehuda G. Assaraf, Shimon Farber et al. · Biomacromolecules · 2009 · 136 citations

Pharmacy, Molecular Pharmaceutics, Pharmacology +17

Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance

Eran Bram, Michal Stark, Shachar Raz et al. · Neoplasia · 2009 · 117 citations · Full text

Medicine, Oncology, Pharmacology +13

Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity

Benny Zhitomirsky, Anna Yunaev, Roman Kreiserman et al. · Cell Death and Disease · 2018 · 113 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers

Yamit Adar, Michal Stark, Eran Bram et al. · Cell Death and Disease · 2012 · 101 citations · Full text

Medicine, Oncology, Pharmacology +17

Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia

Michal Stark, Chen Wichman, Irit Avivi et al. · Blood · 2009 · 90 citations · Full text

Medicine, Molecular Biology, Oncology +9